drugset / Trial / NCT00254241

Safety and Efficacy of Seroquel in First Episode Schizophrenia

NCT00254241

Phase 4 Completed 80 enrolled AstraZeneca
RandomizedParallel-groupSingle-blindTreatment

Summary

To compare the safety, tolerability and efficacy of Seroquel and risperidone in first episode schizophrenia

Timeline

Start
2002-05
Primary completion
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule
Subject Risperidone Other / unclassified

Indications